Global medical aesthetics business Neauvia hosted a breakfast event to unveil new clinical data surrounding its dermal filler range.
At the intimate breakfast at the Hide Mayfair, aesthetic practitioner Dr Lisa Dinley shared her recent findings touching on how Neauvia’s fillers, devices and skincare can be used synergistically, including in autoimmune patients.
Dr Dinley said, “One of the major benefits of the Neauvia filler range is that it has different crosslinking technology to other fillers, which means that it’s safe to use even for patients with autoimmune conditions, as the study revealed today has shown. The other advantage of that crosslinker is that it can be used with energy-based devices because it’s resistant to breaking down through heat exposure – Neauvia’s devices can work alongside the fillers to improve patient outcomes.”
